Publications
- A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients2023 | Faculty of Medicine in Pilsen
- Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy2019 | Faculty of Medicine in Pilsen
- The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation2017 | Faculty of Medicine in Pilsen
- Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation2012 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Intragraft cytomegalovirus infection: results of randomized trial of valacyclovir prophylaxis vs. preemptive valganciclovir therapy in renal transplant recipients2010 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Intragraft cytomegalovirus infection: results of randomized trial of valacyclovir prophylaxis vs. preemptive valganciclovir therapy in renal transplant recipients2010 | Central Library of Charles University
- Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis2009 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis2009 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis2009 | Central Library of Charles University
Loading network view...
